SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001017491-17-000025
Filing Date
2017-03-08
Accepted
2017-03-08 16:03:20
Documents
5
Period of Report
2017-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-konferringassetsale.htm 8-K 55643
2 EXHIBIT 10.1 exhibit101-assetpurchaseag.htm EX-10.1 538097
3 EXHIBIT 10.2 exhibit102-licenseagreement.htm EX-10.2 89699
4 EXHIBIT 10.3 exhibit103-transitionservi.htm EX-10.3 42907
5 EXHIBIT 99.1 exhibit991-pressrelease.htm EX-99.1 13992
  Complete submission text file 0001017491-17-000025.txt   741748
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 17675126
SIC: 2834 Pharmaceutical Preparations